Medicine News Car T Cell Therapy Reaches Beyond Cancer Penn Medicine
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Medicine News Car T Cell Therapy Reaches Beyond Cancer Penn Medicine is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Next-generation "armored" CAR T cell therapy shows promising results in lymphoma patients
A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including ... Read More
CAR T cell therapy could be a highly effective tool against atherosclerosis
A pioneering preclinical study has shown that CAR T cell therapy-a personalized form of immunotherapy used in cancer treatment-could be a highly effective tool against atherosclerosis, the condition ... Read More
Enhanced CAR T cell therapy offers new strategy for lymphoma
A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma. A next-generation "armored" CAR T cell therapy ... Read More
Next-generation CAR T cells could expand solid cancer treatment options
Chimeric antigen receptor (CAR) T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and other blood cancers. But researchers have ... Read More
CAR-T cell therapy for cancer causes 'brain fog,' study shows
Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it. After treatment with CAR-T cells ... Read More
CAR-T cell therapy is revolutionising cancer treatment – here’s how it works
Recreation of CAR-T cells attacking a cancerous melanoma cell. Nemes Laszlo/Shutterstock Personalised medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most ... Read More
Penn professor Carl June discusses medical innovation award, CAR-T cell research in DP interview
Penn Medicine professor Carl June was recently awarded the Broermann Medical Innovation Award 2025 for his work on utilizing CAR-T cells in cancer therapy. Modifying T-cells with chimeric antigen ... Read More
Study reveals why some myeloma patients stay cancer-free for years after CAR T therapy
A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell ... Read More
Dual-Target CAR-T Cell Therapy Slows Glioblastoma Tumors in Phase I Trial
Glioblastoma (GBM) is an aggressive and common brain cancer in adults with average life expectancies of 12–18 months after diagnosis and median survival rate for recurrent GBM ranging from 6–10 months ... Read More
CAR T-Cell Therapy Boosts PFS in Advanced Gastric Cancer
In patients with advanced Claudin-18 isoform 2 (CLDN18.2) -positive gastric or gastroesophageal junction cancers, satricabtagene autoleucel (satri-cel) chimeric antigen receptor (CAR) T-cell therapy ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus